Companies / Brazil
Challenges Ahead For Latin America's ED Market
August 2006 | Market Trend AnalysisLatin America's erectile dysfunction (ED) market is recording strong sales, but competitive trends are shifting in the lucrative sector. Throughout the region, Pfizer's long-standing market leader Viagra (sildenafil) is losing ground to rivals including Lillly/ICOS's Cialis (tadalafil) and Bayer's Levitra
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.



